Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Expenditure

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Expenditure ₹234 Cr₹204 Cr₹200 Cr₹16,826,961 Cr₹167 Cr

What is the latest Total Expenditure of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Expenditure ratio of SYNCOM FORMULATIONS (INDIA) is ₹234 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹234 Cr
Mar2024₹204 Cr
Mar2023₹200 Cr
Mar2022₹16,826,961 Cr
Mar2017₹167 Cr

How is Total Expenditure of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹234 Cr
14.38
Mar2024 ₹204 Cr
2.37
Mar2023 ₹200 Cr
-100.00
Mar2022 ₹16,826,961 Cr
10,062,186.55
Mar2017 ₹167 Cr -

Compare Total Expenditure of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,166.5 Cr 1.2% -9.5% -22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,427.0 Cr 1.6% 0.2% -5.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.2%

-9.5%

-22.2%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses